These intersections thus describe the expected endpoints of angling-induced evolution for different angling intensities.
Results were disappointing: the extent of clinical benefit from monotherapy with either drug hovered near the threshold for statistical significance, with response rates of approximately 10%, and the expected endpoints were not reached.
Recently, Bapineuzumab (directed against the N-terminus of Aβ) and Solanezumab (directed against the central region of Aβ), both not conformation specific antibodies, failed to meet the expected endpoints in clinical phase 3 studies albeit having shown positive results in preceding studies (reviewed in [ 67]).
More recently, Niall Martin and others have argued for the importance of religious motives in Duhem's work (see Martin 1991, Jaki 1991) and it has become clear in the course of Duhem's writings that he expected the endpoint of science to harmonize with the teachings of the Catholic Church.
The expected primary endpoint was a decrease in carer burden in the intervention group three months after receiving the DA.
Thus for a study with 2 groups and 4 assessment points, power set at 0.80, statistical significance set at α = .05 (two tailed), total attrition set at 21%, an effect size set at 0.35 SD, and an expected primary endpoint standard deviation of 4.0 at each time point [ 43], 94 participants per group are required, summing to a total sample of 188 participants.
Two interim analyses are planned when 33 and 67% of the 238 expected primary endpoints have been accrued.
A total number of 540 children (180 SAM and 360 non-SAM) would allow to detect a minimum difference of 8%% in ACPR proportion (87 % in SAM versus 95%% in non-SAM children), with a statistical power of at least 80%% and a 2-sided significance level of 5%%, and 15%% expected missing endpoints.
However, similar results are expected in the endpoint to gateway tunnel method also, as illustrated in Figure 8.
A type 2 biomarker is, 'A marker that is intended to substitute for a clinical endpoint; a surrogate endpoint is expected to predict clinical benefit.' To quantify the potential of surrogate markers at the end of infusion, methods proposed by Li and coworkers [ 36] were utilized using Day 4 values.
